Evaluation of a New Ultra-Low Fat Diet for the Management of Primary Hyperlipidemia in Dogs
The purpose of this project is to evaluate the effectiveness of a new ultra low-fat diet for the management of dogs with primary hyperlipidemia.
An ultra low fat diet will significantly decrease serum cholesterol and triglyceride levels in dogs with primary hyperlipidemia.
Any dog with primary hyperlipidemia is eligible for enrollment into this study unless they have significant organ disease (e.g., kidney failure, chronic liver disease, or other) or secondary causes of hyperlipidemia (diabetes mellitus, hypothyroidism, pancreatitis, diabetes mellitus, hyperadrenocorticism, obesity, cholestasis, protein losing nephropathy,). Hyperlipidemia is being defined as elevation > 500 mg/dL of either serum triglyceride and/or serum cholesterol for the purpose of this study. Common causes of secondary hyperlipidemia will be excluded on baseline assessment. This will likely limit this study to predominantly miniature schnauzers although all breeds will be considered for enrollment.
Each dog will participate in this study for a period of approximately 8 weeks. During participation in this trial, the dog will need to be evaluated by a primary care veterinarian three times (at the beginning of the study, 14 - 18 days after being fed the new low-fat diet that is being labeled for use in dogs with hyperlipidemia, and again 14 to 18 days after the second evaluation). Each visit should take less than 1 hour.
Phone: 979 862 2861979
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.